Health
2020 Tencent Medical Enlightenment Summit: Popularizing Science to Overcome Challenges
SHENZHEN, China, Nov. 8, 2020 /PRNewswire/ -- The Tencent Medical Enlightenment Summit is online today with the theme of "'The Pain." It has brought together top medical leaders and scientists from around the world to share with the public the latest cutting-edge research results in medical field...
2020-11-08 19:00
1932
Merck and Transcenta Collaborate to Advance Continuous Biomanufacturing, Make the 'Facility of the Future' a Reality
* Companies to co-develop a first-of-its-kind, single-use flow-through polishing system for GMP operation * Merck's continuous processing expertise to accelerate Transcenta's development, implementation of continuous bioprocessing platform * Collaboration expected to accelerate affordable ac...
2020-11-08 17:14
3100
Merck to Collaborate with Donghao Lansheng to Pilot New Import Policy in China
* Merck is first international company to pilot the new custom clearance
process SHANGHAI, Nov. 8, 2020 /PRNewswire/ -- On November 6, Merck
2020-11-08 17:08
2465
ZEISS Attends the CIIE for the Third Consecutive Time to Showcase Innovative Optical Technologies
SHANGHAI, Nov. 7, 2020 /PRNewswire/ -- The opening ceremony of the third China International Import Expo (CIIE) took place at the National Convention and Exhibition Center (Shanghai) on November 4, demonstrating China's open and inclusive attitude to the world. This is the third consecutive time ...
2020-11-07 20:45
2953
Daewoong Pharmaceutical Announces Publication of Novel P-CAB Fexuprazan Phase 1 Bridging Study
SEOUL, South Korea, Nov. 6, 2020 /PRNewswire/ -- On October 27, the bridging study results on Fexuprazan, developed by the Korean pharmaceutical company, Daewoong Pharmaceutical (Daewoong; CEOSengho Jeon), was published in the SCI medical journal Alimentary Pharmacology and Therapeutics (AP&T). F...
2020-11-06 22:00
2420
CARE GA Receives Study May Proceed Letter from US FDA to Initiate Phase II Clinical Trial of Senhwa's Silmitasertib in COVID-19 Patients
TAIPEI and SAN DIEGO, Nov. 6, 2020 /PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492), a clinical-stage biopharmaceutical company focused on next generation DNA Damage Response (DDR) therapeutics for the treatment of cancer, today announced its clinical partner- Center for Advanced Research an...
2020-11-06 22:00
3321
XJTLU launches new Academy of Pharmacy
SUZHOU, China, Nov. 6, 2020 /PRNewswire/ -- On 11 November 2020, Xi'an Jiaotong- Liverpool University will launch its new XJTLU Wisdom Lake Academy of Pharmacy. "The biopharmaceutical industry is one of the fastest-growing sectors worldwide," says DrYimin Ding, Vice President of XJTLU. "It is a...
2020-11-06 20:00
2335
Jeju Forum opens to discuss multilateral cooperation on pandemic, security
JEJU, South Korea, Nov. 6, 2020 /PRNewswire/ -- Organized by Jeju Peace Institute, an annual international peace forum opened on the southern resort island of Jeju on Thursday, with a focus on ways to shore up multilateral cooperation in tackling the coronavirus pandemic and promoting regional s...
2020-11-06 17:53
2832
Johnson & Johnson Innovation Announces Three Strategic Collaborations with a Focus on Advancing Healthcare Solutions in China
SHANGHAI, Nov. 6, 2020 /PRNewswire/ -- Johnson & Johnson Innovation, division of Johnson & Johnson (China) Investment Limited, announced today three new collaborations with strategic partners inChina at the third China International Import Expo (CIIE) inShanghai. These latest collaborations, faci...
2020-11-06 16:52
5661
Prebona proves unique, long-term effect against COVID-19/SARS CoV-2
STOCKHOLM, Nov. 6, 2020 /PRNewswire/ -- Independent test-institutes have confirmed that Prebona Disinfect is extremely effective against the coronavirus - SARS CoV-2, COVID-19. The tests, conducted on textiles, shows that before and even after 10 machine washes, Prebona Disinfect still eliminates...
2020-11-06 16:15
1724
New Drug for Gastrointestinal Stromal Tumours (GIST) to be Launched in Australia, New Zealand and South East Asia Following Distribution Agreement
Key Highlights: * Specialised Therapeutics Asia (STA) to make QINLOCK® (ripretinib) available to appropriate patients inAustralia, New Zealand, Singapore, Malaysia and Brunei following exclusive distribution agreement * QINLOCK is already approved by the Therapeutics Good Administration (TGA)...
2020-11-06 05:30
2821
Semaglutide 2.4 mg injection demonstrated significant weight loss versus placebo when added to intensive behavioural therapy
BAGSVÆRD, Denmark, Nov. 6, 2020 /PRNewswire/ -- Results of a phase 3a trial showed that investigational drug semaglutide 2.4 mg once-weekly subcutaneous as an adjunct to intensive behavioural therapy (IBT) demonstrated significantly more body weight loss compared to placebo plus IBT.[i] The STEP ...
2020-11-06 01:50
2331
PolyActiva successfully completes initial clinical trial with Latanoprost FA SR Ocular Implant delivering glaucoma treatment to patients over a six-month period
NEW YORK, Nov. 5, 2020 /PRNewswire/ -- PolyActiva Pty Ltd, a clinical-stage Australian ophthalmology biopharmaceutical company, today announced it has successfully completed its Phase I clinical study for its lead candidate, the Latanoprost FA SR Ocular Implant. The device was well tolerated in ...
2020-11-05 21:00
891
Bactiguard maintains clear growth strategy and updates financial targets
STOCKHOLM, Nov. 5, 2020 /PRNewswire/ -- Bactiguard presents updated financial targets for 2025 in connection with the company's financial report for the third quarter of 2020. Bactiguard's growth strategy for the coming five-year period up to 2025 is based on a continued roll-out of Bactiguard's...
2020-11-05 17:52
6366
MEBO International Attended CIIE for the Third Time
SHANGHAI, Nov. 5, 2020 /PRNewswire/ -- On November 5, 2020, the third CIIE was grandly opened inShanghai. With the theme of "Regenerative World, Healthy Future," MEBO International attended the event again. This year marks the third CIIE and MEBO International has been in the event for three cons...
2020-11-05 17:44
2981
Porton Biologics Launched Gene and Cell Therapy CDMO Platform to Rank Among the Top of Pharma Solutions Platforms
SUZHOU, China, Nov. 5, 2020 /PRNewswire/ -- On November 1, the Opening Ceremony of Porton Biologics Gene and Cell Therapy CDMO Platform was held in Suzhou,China . As Porton Biologics is committed to building an end-to-end gene and cell therapy CDMO service platform, the phase I construction of th...
2020-11-05 15:35
4832
TCM Lianhua Qingwen's Access to Russian Market Marks Its Global Expansion
SHIJIAZHUANG, China, Nov. 5, 2020 /PRNewswire/ -- Yiling Pharmaceutical (002603.SZ) discloses that it has received the Certificate of Registration for Dietary Supplements approved and issued by the authorized agency of Eurasian Economic Union, which indicates that the company's patent drug Lianhu...
2020-11-05 14:08
7659
Asieris Announces Approval of its Phase III Trial of a Novel Single Oral Agent as First-line Treatment for Non-Muscle Invasive Bladder Cancer (NMIBC)
SHANGHAI, Nov. 5, 2020 /PRNewswire/ -- Asieris Pharmaceuticals (Asieris), a China-based biotech company specializing in the development and commercialization of new drugs for the treatment of genitourinary tumors and related diseases, recently announced that the Center for Drug Evaluation (CDE) ...
2020-11-05 13:59
1212
Retailers Need to Adjust to New Consumer Behaviors Shaped by COVID-19, according to Emerson Survey
HONG KONG, Nov. 5, 2020 /PRNewswire/ -- A survey released by Emerson's Commercial & Residential Solutions business shows that consumers have dramatically altered their shopping habits in response to COVID-19, putting pressure on retailers to adapt to changing consumption patterns. More than 8 ou...
2020-11-05 13:19
5209
Gracell Biotechnologies Announces Two Oral Presentations at the ASH Annual Meeting and Exposition 2020
SUZHOU and SHANGHAI, China, Nov. 4, 2020 /PRNewswire/ -- Gracell Biotechnologies Inc. ("Gracell"), a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell therapies for the treatment of cancer, today announced two oral presentations at the...
2020-11-05 11:52
1166
Week's Top Stories
Most Reposted
LINKDOOD Breaks Language Barriers, Ushering a New Era for Cross-Border Romance
[Picked up by 326 media titles]
2024-04-29 06:00
Multiple achievements made in China-Hungary BRI conference
[Picked up by 310 media titles]
2024-05-03 06:59
Dow showcases circular and innovative materials science solutions and industry collaborations at Chinaplas 2024
[Picked up by 293 media titles]
2024-04-30 10:11
Xinhua president, Hungarian economy minister vow to bolster media cooperation
[Picked up by 282 media titles]
2024-05-03 06:25TAILG Makes Grand Appearance at 2024 Asiabike Jakarta, Aiming to Set the Benchmark in Indonesia
[Picked up by 257 media titles]
2024-05-02 01:21
Most Read
/C O R R E C T I O N -- Addverb/
2024-05-03 20:26
7371
Dow showcases circular and innovative materials science solutions and industry collaborations at Chinaplas 2024
2024-04-30 10:11
6145
Multiple achievements made in China-Hungary BRI conference
2024-05-03 06:59
5052
Xinhua president, Hungarian economy minister vow to bolster media cooperation
2024-05-03 06:25
4707
